ARTICLE | Distillery Therapeutics
Neurology
January 17, 2018 7:31 PM UTC
Mouse studies suggest a CRISPR/Cas9-based system that inhibits SOD1 in the CNS could help treat ALS. In a transgenic mouse model of ALS expressing mutant human SOD1, IV injection of Cas9 and a single-...
BCIQ Company Profiles